Thomas G Ksiazek

This inventor holds 11 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health. Active years: 1998-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas G Ksiazek. Retrieved from https://idiyas.com/inventor/thomas-g-ksiazek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 72.7

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 33(Granted Patents)

Location History:

Lilburn, GA (US) (1998 - 2014)
Galveston, TX (US) (2016 - 2019)

Company Filing History:

9 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

3 out of 1,217

The United States of America as Represented by the Department of Health

patents

where one patent can have more than one assignee

Years Active: 1998-2019

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10428314 - Human ebola virus species and compositions and methods thereof (2019-10-01),

2. 10064933 - Recombinant rift valley fever (RVF) viruses and methods of use (2018-09-04),

3. 9790473 - Human Ebola virus species and compositions and methods thereof (2017-10-17),

4. 9439935 - Recombinant rift valley fever (RVF) viruses and methods (2016-09-13),

5. 8673629 - Recombinant Rift Valley fever (RVF) viruses and methods of use (2014-03-18),

6. 7776521 - Coronavirus isolated from humans (2010-08-17),

7. 7220852 - Coronavirus isolated from humans (2007-05-22),

8. 6620913 - Polypeptides of a novel hantavirus (2003-09-16),

9. 5945277 - Strain of hantavirus nucleotide sequences thereof related probes, (1999-08-31),

10. 5916754 - Bayou hantavirus and related methods (1999-06-29),

11. 5853980 - Black creek canal hantavirus and related methods (1998-12-29),

Title: The Innovations of Thomas G Ksiazek

Introduction

Thomas G Ksiazek is a prominent inventor based in Galveston, Texas, known for his significant contributions to the field of virology. With a total of 11 patents to his name, Ksiazek has made remarkable advancements in the detection and treatment of viral infections, particularly those affecting both humans and livestock.

Latest Patents

Among his latest patents is the development of compositions and methods related to the Human Ebola virus species. This patent focuses on compositions that serve as immunogens, designed to elicit an immune response or provide protection against the Ebola Bundibugyo virus (EboBun). The inventive methods outlined in this patent are directed towards the detection and treatment of EboBun infection. Another notable patent involves recombinant Rift Valley fever (RVF) viruses and their methods of use. This patent describes recombinant RVF viruses that include deletions in viral virulence genes, which can be utilized as vaccines to prevent RVF virus infections in both livestock and humans. These recombinant viruses are capable of growing to high titers and providing protective immunity after a single injection.

Career Highlights

Throughout his career, Ksiazek has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and The United States of America as represented by the Department of Health. His work has significantly impacted public health and safety, particularly in the realm of infectious diseases.

Collaborations

Ksiazek has collaborated with notable colleagues in his field, including Stuart T Nichol and Pierre E Rollin. These collaborations have further enhanced the research and development of innovative solutions to combat viral infections.

Conclusion

Thomas G Ksiazek's contributions to virology through his patents and collaborations have made a lasting impact on the field. His work continues to pave the way for advancements in the detection and treatment of viral diseases.

Profile summary based on public USPTO records.